We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Search
Filters
9068 Results

Congress Abstract

Temporal course of late toxicity in patients undergoing pelvic radiation for cervical cancer
Authors: SHEJUL|, Jagadish(1)*[jshejul@gmail.com];Chopra|, Supriya(1);Ranjan|, Nilesh(1);Patil|, Prachi(2);Naidu|, Lavanya(1);Mehta|, Shaesta(2);Mahantshetty|, Umesh(1);
(1)Tata Memorial Center, Radiation Oncology, Mumbai, India;(2)Tata Memorial Center, Medical Gastroenterology, Mumbai, India;
Show Affiliations
2020
Poster
ESTRO 2020

Journal Article

Inter-observer variability of organ contouring for preclinical studies with cone beam Computed Tomography imaging
Authors: Georgios Lappas, Nick Staut, Natasja G. Lieuwes, Rianne Biemans, Cecile J.A. Wolfs, Stefan J. van Hoof, Ludwig J. Dubois, Frank Verhaegen
2022
Physics and Imaging in Radiation Oncology

Congress Abstract

First clinical experience with model-based selection for breast cancer proton therapy
Authors: Verhoeven|, Karolien(1)*[karolien.verhoeven@maastro.nl];Vilches-Freixas|, Gloria(1);Limpens|, Karo(1);Mannens|, Jolein(1);Van der Klugt|, Kim(1);Velders|, Marije(1);Visser|, Femke(1);Peeters|, Stephanie(1);Bosmans|, Geert(1);Boersma|, Liesbeth(1);
(1)Maastro, Department of Radiation Oncology- GROW School for Oncology and Developmental Biology- Maastricht University Medical Centre, Maastricht, The Netherlands;
Show Affiliations
2020
Poster
ESTRO 2020

Congress Abstract

Can baseline or Ra-223-induced changes in the plasma predict progressive disease mCRPC patients?
Authors:

Sapna Lunj1, Yee Pei Song2, Andy Hudson2, Kamlesh Patel2, Hannah Nightingale2, Tim Smith1, Peter Hoskin1, Robert Bristow1, Catharine West1, Ananya Choudhury1, Ananya Choudhury3

1The University of Manchester, Division of Cancer Sciences, Manchester, United Kingdom; 2The Christie NHS Foundation Trust, Clinical Oncology, Manchester, United Kingdom; 3The Christie NHS Foundation Trust, Division of Cancer Sciences, Manchester, United Kingdom

Show Affiliations
2021
Poster
ESTRO 2021

Journal Article

A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients
Authors: Nuradh Joseph, Cathy Taylor, Catherine O’Hara, Ananya Choudhury, Tony Elliott, John Logue, James Wylie
2016
Radiotherapy and Oncology

Journal Article

Challenges of re-irradiation: A call to arms for physicists - and radiotherapy vendors
Authors: Eliana Vasquez Osorio, Charles Mayo, Andrew Jackson, Ane Appelt
2023
Radiotherapy and Oncology

Congress Abstract

APBI versus very APBI in the elderly: a comparison analysis of oncological outcome and late toxicity
Authors:

Jena-Michel Hannoun-Levi1, Daniel Lam Cham Kee1, Jocelyn Gal2, Renaud Schiappa3, Mathieu Gautier4, Marie-Eve Chand5

1Antoine Lacassagne Cancer Center, Radiation Oncology, Nice, France; 2Antoine Lacassagne Cancer Center, 2. Biostatistic Unit, Nice, France; 3Antoine Lacassagne Cancer Center, Biostatistic Unit, Nice, France; 4Antoine Lacassagen Cancer Center, Radiation Oncology, Nice, France; 5ANtoine Lacassagen Cancer Center, Radiation Oncology, Nice, France

Show Affiliations
2021
Oral
WCB 2021 - Online

Congress Abstract

Comparison of a surface-based (SGRT) vs. a laser-based setup in breast cancer radiation therapy.

Authors:

Melanie Machiels1,2, Flávia Horácio1, Nikki De Dooij1, Wim Vingerhoed1, Daan Nevens1,2, Charlotte Billiet1,2, Paul Meijnders1,2, Philip Poortmans1,2, Dirk Verellen1,2

1Iridium Netwerk, Radiation Oncology, Antwerp, Belgium; 2University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium

Show Affiliations
2021
Oral
ESTRO 2021

Congress Abstract

Bone-tropic circulating tumor cell population in mCRPC patients under ablative radiotherapy
Authors:

Daria Klusa1,2, Fabian Lohaus3, Hans Neubauer4, Andre Franken4, Mahdi Rivandi4, Bernhard Polzer5, Dejan Husman6, Michael Kücken7, Tobias Hölscher3, Ina Kurth8, Mechthild Krause9,10,2,3,11, Anna Dubrovska10,2,11, Michael Baumann12,8, Claudia Peitzsch9,2,11

1National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany , Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, GERMANY, and; Helmholtz-Zentrum Dresden – Rossendorf (HZDR), Dresden, Germany; 2OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; 3Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Department of Radiotherapy and Radiation Oncology, Dresden, Germany; 4Heinrich-Heine-University of Düsseldorf, Department of Gynecology and Obstetrics, Düsseldorf, Germany; 5Fraunhofer-Institute for Toxicology and Experimental Medicine, Division of Personalized Tumor Therapy, Regensburg, Germany; 6denovoMATRIX , GmbH, Dresden, Germany; 7Center of Information Services and High-Performance Computing (ZIH), Technische Universität, Dept. for Innovative Methods of Computing, Dresden, Germany; 8German Cancer Research Center (DKFZ), Division of Radiooncology / Radiobiology, Heidelberg, Germany; 9National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 10Helmholtz-Zentrum Dresden -Rossendorf, Institute of Radiooncology – OncoRay, Dresden, Germany; 11German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 12OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden, Germany

Show Affiliations
2021
Poster Discussion
ESTRO 2021

Congress Abstract

Evidence-Based Hypofractionated Radiotherapy Uptake in Europe: An Explorative GIRO-HERO Analysis
Authors: OLIVEIRA|, CAROL(1,2)*[carol.oliveira@kingstonhsc.ca];DEFOURNY|, NOÉMIE(3,4);GASPAROTTO|, CHIARA(3);TAWK|, BOUCHRA(5);RODIN|, DANIELLE(6,7);BORRAS|, JOSEP M(8);GRAU|, CAI(9);LIEVENS|, YOLANDE(4,10);
(1)CANCER CENTER OF SOUTHEASTERN CANADA, DEPARTMENT OF ONCOLOGY, KINGSTON, CANADA;(2)QUEEN'S UNIVERSITY, DEPARTMENT OF ONCOLOGY, KINGSTON, CANADA;(3)EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY, ESTRO, BRUSSELS, BELGIUM;(4)GHENT UNIVERSITY, -, GHENT, BELGIUM;(5)HEIDELBERG ION THERAPY CENTER HIT- GERMAN CANCER RESEARCH CENTER DKFZ, DIVISION OF MOLECULAR & TRANSLATIONAL RADIATION ONCOLOGY, HEIDELBERG, GERMANY;(6)PRINCESS MARGARET CANCER CENTRE TORONTO, RADIATION MEDICINE PROGRAM, TORONTO, CANADA;(7)UNIVERSITY OF TORONTO, DEPARTMENT OF RADIATION ONCOLOGY, TORONTO, CANADA;(8)UNIVERSITY OF BARCELONA, DEPARTMENT OF CLINICAL SCIENCES- IDIBELL, BARCELONA, SPAIN;(9)AARHUS UNIVERSITY HOSPITAL, DEPARTMENT OF ONCOLOGY AND DANISH CENTRE FOR PARTICLE THERAPY, AARHUS, DENMARK;(10)GHENT UNIVERSITY HOSPITAL, DEPARTMENT OF RADIATION ONCOLOGY, GHENT, BELGIUM;
Show Affiliations
2020
Oral
ESTRO 2020
*:*